Tuesday, 14 February 2017

Case 4: A suspicious haematoma

A 75 years old man presented with an enlarging left thigh lump after he fell down from a roof 6 months ago.

He saw a general practitioner few weeks after the injury. Two ultrasounds were performed and the diagnosis of a large intramuscular haematoma was made. He was advised to manage the swelling with warm compress and simple analgesic.

He re-presented today because he noticed that the lump was enlarging and it started to affect his walking, however, there was minimal pain. In addition, he reported weight loss of around 10 kg and feeling fatigue over the last few months.

Physical examination revealed a large firm immobile mass in the medial-posterior aspect of the left thigh. There was significant oedema on his left leg. There was no evidence of neuromuscular compromise of the extremity.

An urgent MRI was performed. (Figure 1)

 
Figure 1



1. What does the MRI show?

Case continues: Patient was referred to an orthopaedic surgeon with a special interest in sarcoma. A biopsy confirmed the diagnosis of a myxofibroidsarcoma.

2. Could this lesion be associated with his injury?

3. Can the use of imaging differentiate a soft tissue sarcoma from a benign haematoma ?

4. Is the delay in diagnosis of soft tissue tumour common?

5. How would you manage this patient?


1. The MRI showed a large intra muscular mass with heterogeneous enhancement measuring in the posteromedial thigh. It rose the possible diagnosis of a sarcoma.


2. An association between trauma and soft tissue sarcoma has been suggested for over 200 years.(5) Currently, there is no evidence to say that the relationship is causal. The usual history is of a traumatic incident occurring shortly prior to the awareness of the mass. Because of the relatively short time frame, we think that the trauma merely brings the patient's attention to the mass. (5)(7).

3. Even with the advances in modern technology, we cannot use imaging to safely differentiate a soft tissue sarcoma from a haematoma.  (2,5,7,8). Gomez et al reported three cases similar to our case study. All three patients had history of trauma prior to consulting their family physicians with lumps. They had MRIs and CTs, and were all initially reported as haematomas. This highlights the difficulty in differentiating malignant tumour from a benign haematoma using imaging alone. The imaging results need to be interpreted in the context of clinical history and examination. When there is enough clinical suspicion of a soft tissue sarcoma, patient should be referred to a specialist unit for biopsy. (8)

4. The delay in diagnosis of soft tissue sarcoma is a common problem. Many studies were conducted in an attempt to identify the sources of delay.  (2,3,4) The identified sources of delay include patient delay in presentation, mis-diagnosis, and waiting for investigations such as imaging and biopsy. The average time frame between the onset of symptoms to patient presentation is around 12 months, and the average time frame between patient presentation to referral to a specialist unit is 13.5 months.

Sarcoma is a rare tumour. There are around 800 new cases diagnosed in Australia per year. Most general surgeons or general practitioners will only encounter a soft tissue sarcoma once or twice in their careers. Therefore, it is important to be vigilant and treat any lump greater than 5 cm or deep to the fascia as sarcoma until proven otherwise.

5. Studies have shown that early referral to a specialist unit improves survival rate and treatment outcome.  Imaging and biopsies at non-specialist units are often inadequate and further delay the diagnosis. Poor biopsy techniques can potentially complicate future surgical excisions. Hence, an early referral for biopsy or management is recommended.

Case continue

Further imaging at the specialist unit showed pulmonary metastases. He underwent radiotherapy and definite surgical excision. The surgical excision was of palliative intent due to his pulmonary metastases. At the time of writing, he had returned home and recovered well from his surgery. He will require regular review and ongoing surveillance .

Key points:
- Any lumps greater than 5cm in diameter or deep in fascia should be treated as sarcoma until proven otherwise.
- Imaging results need to interpreted in the context of clinical history and examination. A biopsy is required to exclude soft tissue sarcoma.
- An early referral to a specialist unit provides the best survival rate and treatment outcome.


References:

Cancer Council Australia Sarcoma Guidelines Working Party. Clinical practice guidelines for the management of adult onset sarcoma.
Sydney: Cancer Council Australia. [Version URL: http://wiki.cancer.org.au/australiawiki/index.php?oldid=138276, cited 2017 Apr 11].

Available from: http://wiki.cancer.org.au/australia/Guidelines:Sarcoma
2. Ashwood N, Witt JD, Hallam PJ, Cobb JP. Analysis of the referral pattern to a supraregional bone and soft tissue tumour service. Ann R Coll Surg Engl 2003 Jul;85(4):272-6 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/12855033.
4. Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. Br J Cancer 2006 Jan 16;94(1):22-9 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/16317433
5. Soft tissue sarcomas of the extremities. Blake A. Morrison. Available at
6. Uptodate pathogenetic factors in soft tissue and bone sarcomas
7. http://www.bcmj.org/article/soft-tissue-sarcomas-extremities-how-stay-out-trouble
8. High grade sarcomas mimicking traumatic intramuscular hematoms: a report of three cases. Pablo Gomez and jose Morcuende Available at:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1888428/pdf/1555-1377v024p106.pdf
SaveSave
SaveSaveSaveSave
SaveSave
SaveSaveSaveSaveSaveSave
SaveSave

Wednesday, 8 February 2017

Case 3: Lung function test

68 yr old male came for regular check up.

He had a lung function test last year.

He used to be a heavy smoker, quit last year. His exercise tolerance is limited to around 50m.


What is your diagnosis ?

With a long smoking history and shortness of breath, this lung function indicates Chronic Obstructive Pulmonary Disease (COPD) . COPD is confirmed by the presence of persistent airflow limitation. FEV1/FVC < 0.7.

The problem we are having now is that we over diagnose people with COPD. Around 20-30% of patients who have a diagnosis of COPD has never had spirometry. Remember, COPD is a spirometry diagnosis.

What are your differential diagnoses?

COPD has many causes including asthma, smoking, occupation exposures, and anti tripsin 1 deficiency.

Is this severe disease ?

The current classification from lung foundation Australia classify this patient with severe disease.


How would you manage this patient?

This patient requires multi-disciplinary approach. 

  1. GP management plan and TCA
  2. Prevention of exacerbation: flu vaccination and pneumococcal vaccination
  3. Stop smoking 
  4. Optimise medications: use COPD stepwise treatment flowchart (link)
  5. COPD action plan 
  6. Refer to lung rehabilitation or physiotherapist or exercise physiologist to improve lung function 
  7. Regular review and assess inhaler techniques 
According to the latest COPD guideline, severe COPD with more than 2 exacerbations per year should be managed by LABA + Inhale corticosteroid. 

Reference:
1. COPD-X concise guideline





Sunday, 5 February 2017

Jaundice



68 yr old woman presented with jaundice. (Really jaundice, sort of like simpson kind of yellow)

It started 2 weeks ago. There is intermittent abdominal discomfort but mostly pain free. She noted that her stool is getting pale and hard to flush. The urine is getting darker and darker.

She is otherwise well. Not any medication. Denies ETOH abuse or any new medications.

This is the first time you see her.

Examination is essentially normal other than jaundice. She is haemodynamically stable, afebrile. Abdomen is soft, non tender, no ascites and no hepatomegaly.

What are your differentials at this stage ? How would you manage this patient ?

A structured approach will break down jaundice into pre, intra and post hepatic cause.

 In my mind, I thought this is going to be carcinoma of head of the pancreas. (Painless jaundice).

I was putting all my money on post hepatic jaundice.

The differentials listed in Murtagh
  • Intrahepatic 
    • Alcoholic hepatitis/cirrhosis 
    • Drugs
    • Primary biliary cirrhosis 
    • Viral hepatitis 
  • Extrahepatic 
    • Cancer of bile ducts
    • Cancer of pancreas
    • Other cancer: primary or secondary spread
    • Cholangitis
    • Pimary sclerosing cholangitis 
    • Common bile duct gallstones
    • Pancreatitis
    • Post-surgical biliary stricture or oedema 
I spoke to my supervisor because I thought about sending this patient to the hospital. 

The final decision was that we started the initial work up first. 

What investigations would you order? Any bedside test?



I contemplated whether to send this woman to hospital to work up in the community. Because she was well so I decided to order some blood tests and review her in a few days time. 

The blood tests I ordered at that time: FBE, LFT, Ca-125, ESR, CRP, UEC, Hepatitis B, Hepatitis A and hepatitis C serology, urinalysis


Hepatitis screen is normal.

The following is the LFT.   What does it tell you and What would you do now ?


This LFT picture is worrying. The bilirubin is 20 times over the normal limit. Combining this with the derrange ALP and GGT. This lady requires an urgent decompression. I ordered an urgent CT chest, abdo and pelvis. The following is the report. 


 It shows gross intrahepatic biliary dilatation likely secondary to cholangiocarcinoma. I contacted one of the local surgeons and he said this patient needs urgent decompression. 

She was transferred to a tertiary hospital for urgent decompression. An ERCP was performed and a stent was inserted. The surgery was complicated by post-op haematoma and re-obstruction. The obstruction subsequently resolve by itself and patient was discharged with out patient upper GI follow up for curable surgery. 


Lessons learned from this case:
- Get advice from other people when you are not sure
- Needs a structured approach to jaundice 
- Clinical appearance can be deceiving
- Urinalysis can be helpful in determining the cause of jaundice. The presence of bilirubin in urine  and the absence of urobilinogen indicates post hepatic obstruction.



Thursday, 29 December 2016

Dermatofibrosarcoma protuberans (DFSP)

What is dermatofibrosarcoma protuberans?

  • Rare tumour 
  • most likely to be of fibroblastic lineage
How does it present?
  • it has smooth appearance resembling a keloidal scar
  • its site on the trunk in young to middle-aged patients
What is the management
  • excision with wide surgical margins 
Reference:
  • Primary certificate of dermatology RACGP 

Benign lymphocytic infiltrates

What is benign lymphocytic infiltrates?

  • The are benign infiltrates of lymphocytes occurring in the dermis
  • They are categorised into B cell and T cell proliferations. 
  • Lymphocytoma cutis is the name used for B cell infiltrates
  • Jessner's lymphocytic infiltrate is an example of a T-cell pseudo lymphoma 
How does it present?
  • Rare
  • The presentation is often in the third or fourth decade of life, but may occur at any age 
  • They present as smooth red apple,es, plaques or nodules, which may be multiple and coalesce
  • The face is most commonly involved, including the ear lobes

What the skin biopsy shows?
  • moderately dense infiltrate lymphocytes within the dermis 
  • distinction from lymphoma is sometimes difficult

What is the management?
  • typical treatment includes
    • potent topical steroids 
    • intralesional steroids 
    • phototherapy 
    • hydroxychloroquine 
  • spontaneous resolution sometimes occur 
  • recurrence is common 
  • small number may progress to lymphoma 
Reference:
  • Primary certificate of dermatology RACGP 

Cutaneous B-cell lymphoma (CBCL)


What is cutaneous B-cell lymphoma (CBCL)?


  • It can be either primary disease of the skin or secondary from nodal (non-Hodgkin's) lymphoma
  • It is rare and less common than mycosis fungicides
  • Men are more commonly affected, most cases present in the sixth or seventh decade of life


How does it present?
  • solitary or multiple nodules localised to one area of the body
  • Usually pink or violaceous in colour, smooth, firm, non tender 
  • favour neck and head region
  • lymph nodes in other area may be involved 

What does it look like on skin biopsy?

  • dense infiltrate of lymphocytes throughout the mid and lower dermis 
  • B lymphocytes do not localise to the epidermis, hence, no scale
What is the treatment ? 
  • Referral to a dermatologist or oncologist is recommended for staging and treatment 
  • Treatment options 
    • radiotherapy 
    • surgery for localised lesion s
    • chemotherapy 
    • rituximab 
What is the prognosis?
  • In general good prognosis > 90 % 5 year survival rate for the follicle centre and marginal zone b cell lymphoma 
  • less so for the variant occurring on the legs 
  • Secondary CBCL is associated with a poor prognosis 
Reference:
1. primary certificate of dermatology RACGP 

Wednesday, 28 December 2016

Tennis Elbow


Tennis elbow is quite a common presentation at general practice. The diagnosis is usually quite straight forward, occasionally, it is complicated by referred neck pain. Most of the time, the patient will be able to tell you the diagnosis is Tennis Elbow.


What is the management?


  • There are many treatments available. Why ? Because none is effective. 
  • Treatments include:
    • physiotherapy: ultrasound, manual therapy
    • NSAIDs: oral, topical. Some mild benefit with topical NSAID gel. 
    • ESWT: no benefit. Cochrane recommended against it. 
    • Surgery: no evidence. Final Resort. 
    • Platelets rich plasma : no definite conclusion can be drawn. No benefit has been shown so far. 
    • orthotic device : no definite conclusion can be drawn. 
    • GTN patch: not mentioned in cochrane. Usually used in combination with an exercise program. 

I looked at cochrane review, there is no evidence for any particular treatment.

The following is a succinct summary from reference 1. 

Essentially, in acute stage, watch and wait. 
Subacute stage, refer to physiotherapy or structured exercise program. 
Chronic stage, can try cortisone injection. Refer for specialist opinion. 

Patient handout: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/elbow-pain
(I read quite a few handouts online and I found the one from the victoria state government to be the most accurate and up to date)

References:
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781883/
2. http://www.cochrane.org/CD001821/MUSKEL_orthotic-devices-for-the-treatment-of-tennis-elbow